BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29567209)

  • 1. Heterotopic Ossification: The Keys to the Kingdom.
    Kaplan FS; Pignolo RJ; Shore EM
    Bone; 2018 Apr; 109():1-2. PubMed ID: 29567209
    [No Abstract]   [Full Text] [Related]  

  • 2. A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings.
    Amalfitano M; Fyfe B; Thomas SV; Egan KP; Xu M; Smith AG; Kaplan FS; Shore EM; Pignolo RJ
    Bone; 2018 Apr; 109():56-60. PubMed ID: 29320714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Vascularity in Genetic and Nonhereditary Heterotopic Ossification.
    Ware AD; Brewer N; Meyers C; Morris C; McCarthy E; Shore EM; James AW
    Int J Surg Pathol; 2019 Dec; 27(8):859-867. PubMed ID: 31250694
    [No Abstract]   [Full Text] [Related]  

  • 4. Endochondral ossification in a case of progressive osseous heteroplasia in a young female child.
    Schrander DE; Welting TJ; Caron MM; Schrander JJ; van Rhijn LW; Körver-Keularts I; Schrander-Stumpel CT
    J Pediatr Orthop B; 2014 Sep; 23(5):477-84. PubMed ID: 24626099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva.
    Wentworth KL; Bigay K; Chan TV; Ho JP; Morales BM; Connor J; Brooks E; Shahriar Salamat M; Sanchez HC; Wool G; Pignolo RJ; Kaplan FS; Hsiao EC
    Bone; 2018 Apr; 109():104-110. PubMed ID: 29033382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.
    Kawao N; Yano M; Tamura Y; Okumoto K; Okada K; Kaji H
    J Bone Miner Metab; 2016 Sep; 34(5):517-25. PubMed ID: 26204847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive osseous heteroplasia.
    Kaplan FS; Shore EM
    J Bone Miner Res; 2000 Nov; 15(11):2084-94. PubMed ID: 11092391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
    Ravazzolo R; Cappato S; Bocciardi R
    Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrodysplasia ossificans progressiva in Brazil: challenges and strategies to create assistance and educational networks.
    Zorzi AR; Delai PR; Rosa HLC; Brito WE; Montalli VAM; Napimoga JC; Napimoga MH; Nociti FH
    Orphanet J Rare Dis; 2022 Sep; 17(1):348. PubMed ID: 36071499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification.
    Cong Q; Liu Y; Zhou T; Zhou Y; Xu R; Cheng C; Chung HS; Yan M; Zhou H; Liao Z; Gao B; Bocobo GA; Covington TA; Song HJ; Su P; Yu PB; Yang Y
    Sci Transl Med; 2021 Jun; 13(599):. PubMed ID: 34162750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive osseous heteroplasia in a 5-year-old boy with a novel mutation in exon 2 of GNAS: a case presentation and literature review.
    Ma J; Mo W; Sun J; Li Y; Han T; Mao H
    BMC Musculoskelet Disord; 2023 Mar; 24(1):247. PubMed ID: 37003989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotopic ossification.
    Kaplan FS; Glaser DL; Hebela N; Shore EM
    J Am Acad Orthop Surg; 2004; 12(2):116-25. PubMed ID: 15089085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.
    Kaplan FS; Zeitlin L; Dunn SP; Benor S; Hagin D; Al Mukaddam M; Pignolo RJ
    Bone; 2018 Apr; 109():281-284. PubMed ID: 29241828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m MDP demonstration of heterotopic ossification in fibrodysplasia ossificans progressiva.
    Fang MA; Reinig JW; Hill SC; Marini J; Zasloff MA
    Clin Nucl Med; 1986 Jan; 11(1):8-9. PubMed ID: 3080267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analog Method for Radiographic Assessment of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva.
    Rajapakse CS; Lindborg C; Wang H; Newman BT; Kobe EA; Chang G; Shore EM; Kaplan FS; Pignolo RJ
    Acad Radiol; 2017 Mar; 24(3):321-327. PubMed ID: 27989444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
    J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic disorders with heterotopic ossificans.
    Sankar R; Gowrishankar K; Viswanathan S
    Indian J Orthop; 2015; 49(3):361-4. PubMed ID: 26015640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP).
    Kaplan FS; Al Mukaddam M; Pignolo RJ
    Bone; 2017 Aug; 101():123-128. PubMed ID: 28465250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrodysplasia ossificans progressiva and osteoimmunology].
    Katagiri T
    Clin Calcium; 2016 May; 26(5):691-8. PubMed ID: 27117614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.